title: Estrogen receptor mutations found in breast cancer metastases integrated with the molecular pharmacology of selective ER modulators.
abstract: The consistent reports of mutations at Asp538 and Tyr537 in helix 12 of the ligand-binding domain (LBD) of estrogen receptors (ERs) from antihormone-resistant breast cancer metastases constitute an important advance. The mutant amino acids interact with an anchor amino acid, Asp351, to close the LBD, thereby creating a ligand-free constitutively activated ER. Amino acids Asp 538, Tyr 537, and Asp 351 are known to play a role in either the turnover of ER, the antiestrogenic activity of the ER complex, or the estrogen-like actions of selective ER modulators. A unifying mechanism of action for these amino acids to enhance ER gene activation and growth response is presented. There is a range of mutations described in metastases vs low to zero in primary disease, so the new knowledge is of clinical relevance, thereby confirming an additional mechanism of acquired resistance to antihormone therapy through cell population selection pressure and enrichment during treatment. Circulating tumor cells containing ER mutations can be cultured ex vivo, and tumor tissues can be grown as patient-derived xenografts to add a new dimension for testing drug susceptibility for future drug discovery.
authors.affiliation: MD Anderson Cancer Center, Department of Breast Medical Oncology, Houston, TX (VCJ, PYM); Institute of Chemistry, Romanian Academy, Timisoara, Romania (RC). vcjordan@mdanderson.org.
authors.forename: V Craig
authors.initials: VC
authors.lastname: Jordan
authors.affiliation: MD Anderson Cancer Center, Department of Breast Medical Oncology, Houston, TX (VCJ, PYM); Institute of Chemistry, Romanian Academy, Timisoara, Romania (RC).
authors.forename: Ramona
authors.initials: R
authors.lastname: Curpan
authors.affiliation: MD Anderson Cancer Center, Department of Breast Medical Oncology, Houston, TX (VCJ, PYM); Institute of Chemistry, Romanian Academy, Timisoara, Romania (RC).
authors.forename: Philipp Y
authors.initials: PY
authors.lastname: Maximov
mesh_terms: D001224:Aspartic Acid; D001943:Breast Neoplasms / Q000235:genetics* / Q000473:pathology*; D005260:Female; D064593:Heterografts; D006801:Humans; D009154:Mutation; D011960:Receptors, Estrogen / Q000235:genetics*; D020845:Selective Estrogen Receptor Modulators / Q000494:pharmacology*; D014443:Tyrosine
chemical_list: D011960:Receptors, Estrogen; D020845:Selective Estrogen Receptor Modulators; D001224:Aspartic Acid; D014443:Tyrosine
references.citation: Mol Endocrinol. 1999 Nov;13(11):1912-23
references.pmid: 10551784
references.citation: Clin Cancer Res. 2000 May;6(5):2028-36
references.pmid: 10815929
references.citation: Cancer Res. 2000 Aug 1;60(15):4026-9
references.pmid: 10945602
references.citation: Cancer Res. 2000 Sep 15;60(18):5097-105
references.pmid: 11016635
references.citation: Cancer Res. 2001 May 1;61(9):3632-9
references.pmid: 11325832
references.citation: Cancer Res. 2001 Sep 15;61(18):6619-23
references.pmid: 11559523
references.citation: J Natl Cancer Inst. 2001 Nov 21;93(22):1714-23
references.pmid: 11717332
references.citation: J Biol Chem. 2002 Mar 15;277(11):9189-98
references.pmid: 11751902
references.citation: J Biol Chem. 2002 Apr 12;277(15):13202-9
references.pmid: 11823467
references.citation: J Clin Oncol. 2002 Aug 15;20(16):3386-95
references.pmid: 12177098
references.citation: J Clin Oncol. 2002 Aug 15;20(16):3396-403
references.pmid: 12177099
references.citation: J Biol Chem. 2003 Feb 28;278(9):7630-8
references.pmid: 12496244
references.citation: J Med Chem. 2003 Mar 13;46(6):883-908
references.pmid: 12620065
references.citation: J Biol Chem. 2003 Jul 18;278(29):27278-86
references.pmid: 12736255
references.citation: Clin Cancer Res. 2003 Jun;9(6):1980-9
references.pmid: 12796359
references.citation: Ann Oncol. 1992 Sep;3(8):611-7
references.pmid: 1450042
references.citation: Cancer Cell. 2004 Mar;5(3):207-13
references.pmid: 15050912
references.citation: J Natl Cancer Inst. 2004 Jun 16;96(12):926-35
references.pmid: 15199112
references.citation: J Natl Cancer Inst. 1992 Apr 15;84(8):580-91
references.pmid: 1556769
references.citation: J Natl Cancer Inst. 2005 Sep 7;97(17):1254-61
references.pmid: 16145046
references.citation: J Natl Cancer Inst. 2005 Dec 7;97(23):1746-59
references.pmid: 16333030
references.citation: Mol Cell Endocrinol. 2006 Feb 26;246(1-2):83-90
references.pmid: 16442702
references.citation: JAMA. 2006 Jun 21;295(23):2727-41
references.pmid: 16754727
references.citation: Steroids. 2007 Jan;72(1):7-25
references.pmid: 17169390
references.citation: Mol Endocrinol. 2007 Apr;21(4):829-42
references.pmid: 17185393
references.citation: Cancer Res. 1992 Jan 15;52(2):483-6
references.pmid: 1728420
references.citation: Protein Sci. 2007 May;16(5):897-905
references.pmid: 17456742
references.citation: Mol Endocrinol. 2008 Jan;22(1):65-77
references.pmid: 17872378
references.citation: Cancer Res. 2007 Oct 1;67(19):9549-60
references.pmid: 17909066
references.citation: J Clin Oncol. 2008 Jun 20;26(18):3073-82
references.pmid: 18519949
references.citation: J Clin Invest. 1991 Aug;88(2):700-6
references.pmid: 1864980
references.citation: Mol Cell Endocrinol. 2008 Nov 25;295(1-2):94-100
references.pmid: 18762230
references.citation: JAMA. 2009 Aug 19;302(7):774-80
references.pmid: 19690310
references.citation: Cancer Res. 1991 Jan 1;51(1):105-9
references.pmid: 1988075
references.citation: J Clin Oncol. 2010 Jan 20;28(3):509-18
references.pmid: 19949017
references.citation: N Engl J Med. 2010 Feb 25;362(8):686-96
references.pmid: 20181970
references.citation: Cancer Prev Res (Phila). 2010 Jun;3(6):696-706
references.pmid: 20404000
references.citation: Br Med J. 1944 Sep 23;2(4368):393-8
references.pmid: 20785660
references.citation: Cancer Res. 1990 Feb 1;50(3):451-8
references.pmid: 2105155
references.citation: Breast Cancer Res. 2011 Mar 01;13(2):R21
references.pmid: 21362200
references.citation: J Clin Oncol. 2011 Apr 20;29(12):1592-8
references.pmid: 21422422
references.citation: Mol Pharmacol. 2011 Oct;80(4):610-20
references.pmid: 21737572
references.citation: Lancet. 2011 Aug 27;378(9793):771-84
references.pmid: 21802721
references.citation: Breast. 2011 Oct;20 Suppl 3:S42-9
references.pmid: 22015292
references.citation: Cancer Res. 1990 Nov 15;50(22):7285-92
references.pmid: 2224859
references.citation: Oncogene. 2012 Nov 15;31(46):4868-77
references.pmid: 22266855
references.citation: Lancet Oncol. 2012 May;13(5):476-86
references.pmid: 22401913
references.citation: Mol Endocrinol. 2012 Sep;26(9):1567-77
references.pmid: 22865929
references.citation: Cancer Res. 1990 Jan 15;50(2):333-8
references.pmid: 2295073
references.citation: Lancet. 2013 Mar 9;381(9869):805-16
references.pmid: 23219286
references.citation: Horm Mol Biol Clin Investig. 2012 Feb;9(2):143-163
references.pmid: 23308083
references.citation: Clin Cancer Res. 2013 May 1;19(9):2420-31
references.pmid: 23536434
references.citation: EMBO J. 1990 Jul;9(7):2221-31
references.pmid: 2357968
references.citation: Menopause. 2013 Apr;20(4):372-82
references.pmid: 23921472
references.citation: Cell Rep. 2013 Sep 26;4(6):1116-30
references.pmid: 24055055
references.citation: PLoS One. 2013 Sep 18;8(9):e75038
references.pmid: 24058649
references.citation: Eur J Cancer. 2014 Jan;50(2):457-68
references.pmid: 24183378
references.citation: Nat Genet. 2013 Dec;45(12):1446-51
references.pmid: 24185510
references.citation: Nat Genet. 2013 Dec;45(12):1439-45
references.pmid: 24185512
references.citation: Cell Rep. 2013 Nov 14;5(3):637-45
references.pmid: 24210818
references.citation: Cancer Res. 2013 Dec 1;73(23):6856-64
references.pmid: 24217577
references.citation: Mol Cancer Ther. 2014 Jan;13(1):230-8
references.pmid: 24227889
references.citation: Science. 2013 Nov 29;342(6162):1094-8
references.pmid: 24288332
references.citation: J Natl Cancer Inst. 2014 Jan;106(1):djt337
references.pmid: 24317176
references.citation: PLoS One. 2013 Dec 18;8(12):e84189
references.pmid: 24367641
references.citation: Clin Cancer Res. 2014 Apr 1;20(7):1757-1767
references.pmid: 24398047
references.citation: Mol Pharmacol. 2014 May;85(5):789-99
references.pmid: 24608856
references.citation: Endocr Relat Cancer. 2014 May 06;21(3):R235-46
references.pmid: 24659478
references.citation: Br J Pharmacol. 2014 Sep;171(17):4062-72
references.pmid: 24819221
references.citation: Ann Oncol. 2014 Sep;25(9):1729-35
references.pmid: 25009010
references.citation: Science. 2014 Jul 11;345(6193):216-20
references.pmid: 25013076
references.citation: Eur J Cancer. 2014 Nov;50(16):2866-76
references.pmid: 25204804
references.citation: Eur J Cancer. 2014 Nov;50(16):2877-86
references.pmid: 25212499
references.citation: J Natl Cancer Inst. 2014 Sep 30;106(11):null
references.pmid: 25269699
references.citation: Endocr Relat Cancer. 2015 Feb;22(1):R1-31
references.pmid: 25339261
references.citation: Cancer Res. 1989 Aug 1;49(15):4090-3
references.pmid: 2743303
references.citation: Cancer Res. 1989 Sep 1;49(17):4765-9
references.pmid: 2758410
references.citation: EMBO J. 1989 Jul;8(7):1981-6
references.pmid: 2792078
references.citation: Lancet. 1987 Jan 3;1(8523):36
references.pmid: 2879105
references.citation: Nature. 1985 Jun 13-19;315(6020):546
references.pmid: 2989691
references.citation: Nature. 1986 Dec 18-31;324(6098):615-7
references.pmid: 3025739
references.citation: J Lab Clin Med. 1987 Mar;109(3):267-77
references.pmid: 3102656
references.citation: Cancer Res. 1988 Sep 15;48(18):5183-7
references.pmid: 3409244
references.citation: Eur J Cancer Clin Oncol. 1987 Dec;23(12):1935-9
references.pmid: 3436356
references.citation: Eur J Cancer Clin Oncol. 1987 Aug;23(8):1189-96
references.pmid: 3653212
references.citation: Cell. 1987 Dec 24;51(6):941-51
references.pmid: 3690665
references.citation: Science. 1986 Mar 7;231(4742):1150-4
references.pmid: 3753802
references.citation: Br J Pharmacol. 1986 Jan;87(1):217-23
references.pmid: 3955300
references.citation: Pharmacol Rev. 1984 Dec;36(4):245-76
references.pmid: 6395141
references.citation: Mol Pharmacol. 1984 Sep;26(2):279-85
references.pmid: 6541293
references.citation: J Biol Chem. 1983 Apr 25;258(8):4741-5
references.pmid: 6833272
references.citation: N Engl J Med. 1981 Jan 1;304(1):16-21
references.pmid: 7001242
references.citation: Mol Endocrinol. 1995 Jul;9(7):814-25
references.pmid: 7476965
references.citation: Mol Endocrinol. 1995 Aug;9(8):1053-63
references.pmid: 7476979
references.citation: Mol Endocrinol. 1995 Jan;9(1):24-33
references.pmid: 7539106
references.citation: J Clin Endocrinol Metab. 1995 Oct;80(10):2918-25
references.pmid: 7559875
references.citation: Mol Endocrinol. 1995 Apr;9(4):457-66
references.pmid: 7659089
references.citation: Proc Natl Acad Sci U S A. 1995 May 9;92(10):4206-10
references.pmid: 7753783
references.citation: Breast Cancer Res Treat. 1994;31(1):117-27
references.pmid: 7981452
references.citation: Breast Cancer Res Treat. 1994;31(1):129-38
references.pmid: 7981453
references.citation: Cancer Lett. 1994 Jul 29;82(2):123-8
references.pmid: 8050081
references.citation: Mol Endocrinol. 1993 Nov;7(11):1408-17
references.pmid: 8114756
references.citation: Mol Endocrinol. 1994 Jan;8(1):21-30
references.pmid: 8152428
references.citation: J Biol Chem. 1993 Nov 15;268(32):24089-98
references.pmid: 8226955
references.citation: Cancer Res. 1994 Jan 15;54(2):349-53
references.pmid: 8275466
references.citation: Recent Results Cancer Res. 1993;127:23-33
references.pmid: 8502820
references.citation: Cancer Res. 1996 May 15;56(10):2321-30
references.pmid: 8625307
references.citation: Mol Endocrinol. 1996 Mar;10(3):230-42
references.pmid: 8833652
references.citation: Br J Cancer. 1996 Oct;74(8):1227-36
references.pmid: 8883409
references.citation: Mol Endocrinol. 1996 Nov;10(11):1388-98
references.pmid: 8923465
references.citation: Cancer Res. 1997 Apr 1;57(7):1244-9
references.pmid: 9102207
references.citation: J Steroid Biochem Mol Biol. 1997 Mar;60(5-6):261-8
references.pmid: 9219916
references.citation: Cancer Res. 1997 Aug 1;57(15):3071-8
references.pmid: 9242427
references.citation: Mol Endocrinol. 1997 Aug;11(9):1375-86
references.pmid: 9259327
references.citation: Nature. 1997 Oct 16;389(6652):753-8
references.pmid: 9338790
references.citation: Cancer Res. 1998 May 1;58(9):1872-5
references.pmid: 9581827
references.citation: J Natl Cancer Inst. 1998 Jul 1;90(13):967-71
references.pmid: 9665143
references.citation: Cell. 1998 Dec 23;95(7):927-37
references.pmid: 9875847